For a very long time, I was convinced that I understood the inner machinations of social media. I truly believed that given how colorful my iPhone’s home screen was due to the cornucopia of collective apps placed strategically in folders based on what purpose the app served in my life.
Currently seated in my “social stuff” folder are apps like Facebook (FB) and Instagram (FB), staples in a content creator’s arsenal, along with YouTube (GOOG) and Skype (MSFT), for work purposes, of course. I waited to mention that I also use Snapchat (SNAP), the media sharing app created by parent company Snap Inc. (SNAP), because, to be completely honest, my use of the app makes me feel dated. I would wager several CVS coupons and a buffalo nickel that I belong to a dying breed of Snapchat (SNAP) users, a group of vagrants who no longer have even a single finger on the pulse of what’s trending and #relevant.
Many moons ago, Evan Spiegel Snap’s CEO (SNAP) decided that the Snapchat app, albeit an immense success at the time, was due for a facelift. He insisted that the company redesign the user interface of the app by creating a new “Discover” section for creators to share ideas, videos, and other interesting content. Suffice to say Snapchat’s (SNAP) redesign was taken very poorly. In August, the company announced its second-quarter daily average users had dropped 2% to 188 million. It probably didn’t help that Kylie Jenner, a celebrity famous for something I’ve lost track of, tweeted asking “does anyone else not open Snapchat anymore? Or is it just me…ugh, this is so sad.” Ms. Jenner’s candor aside, the tweet knocked off more than $1 billion of Snap Inc’s market value at the time.
“We’re watching a company explode into bits. This is the kiss of death to a brand like Snapchat with their base that has stuck with them.”
–Eric Schiffer, Chief Executive Officer, Patriarch Organization
According to Bloomberg, four of the last six quarters since Snap’s initial public offering in March 2017 have fallen short in terms of projected revenue for the company, and everyone seems to be waving their fingers and unimpressive bank statements at Evan Spiegel. The question is really whether Spiegel has any sense of where Snap Inc (SNAP) is going, and if so, what in the name of H.G. Wells is he thinking?
In late 2016, Snap Inc. (SNAP) decided it was a camera company and developed “Spectacles,” a pair of sunglasses with a camera embedded in the lens for the purpose of snapping pictures and video. Sounds like a cool product, right? Well, it would’ve been if not for the fact that the glasses could only be used on the Snapchat app. Last year, the company ate $40 million in unsold inventory after the company ordered roughly 800,000 units from China.
To put it very simply, I fear for the life of Snap Inc. (SNAP) and so do investors. Shareholders that were once proud to own stock in Snap (SNAP) are now fleeing in droves, largely in part to the fact that Snap’s shares are trading roughly 60% below its March 2017 IPO price, currently at $6.51 per share, according to recent reports. Spiegel doesn’t seem to know when to quit, as a recent report from Cheddar indicates that Snap Inc. plans on releasing yet another version of its Spectacles glasses, this time with two cameras and a higher price point of $350 per pair.
My lack of understanding of Evan Spiegel seemingly has no end. If you release a product that consumers demonstrate little to no interest in, why would you spend more money on building out the capabilities of the product? It’s not that people don’t think Spectacles aren’t cool, in fact, they’re really sick. The issue is paying nearly $400 for cheap sunglasses that record 20 seconds of video only to be shared on a social platform that no one uses anymore.
During a meeting with Snapchat employees back in July, someone asked what was meant by Snap’s mission statement, “to contribute to human progress by allowing people to express themselves.” Spiegel responded calmly and said that he believes that “one of the things that have been really helpful in maybe the past six months or so is that the contrast is starting to become more clear between our company and the other companies in technology.”
Yes, Mr. Spiegel, I fear this is true and, if you don’t make some favorable changes, this may not bode well for your company.
Housing Market Sales Of Existing Homes Dropped 5% In March
Properties Staying On The Market For 36 Days On Average
In March, housing market sales ran at an adjusted annual rate of 5.21 million according to the National Association of Realtors. This missed the Econoday consensus rate of 5.3 million and it was lower by 4.9% compared to February.
Market Headwinds Attributed to the Drop
The housing market sales of previously owned homes declined sharply in the month of March compared to what was expected. This was a result of the housing market headwinds.
In February the sector experienced a surge which is the strongest that the industry has had in over four years. The National Association of Realtors lobby group has attributed the decline in March to the return to normalcy following the surge. However, housing market sales were still lower by 5.4% compared to last year.
In March, the median price for homes sold was $259,400 which was a 3.8% increase from last year. Based on the current pace of house sales, it will take around 3.9 months to completely exhaust the available units which are below the 6 months long-term average. Although, in March properties stayed on the market for around 36 days. This is down from the 44 days reported in February. This was, however, longer than last year’s 30 days average.
New Buyers Accounted for 33% of Purchases
The National Association of Realtors reported that first-time buyers accounted for 33% of all purchases in the month of March. Research by NAR indicated that the first time buyers’ market share has relatively remained the same for the last two decades.
Although activity was mixed regionally, all regions experienced a drop in housing market sales. For instance, in the Northeast, there was a 2.9% sales drop while in the south, there was a 3.4% decline. The West has suffered for quite some time because of tax law changes and saw a drop of 6%. The Midwest has experienced the largest decline at 7.9%.
Over the past few months the housing market has suffered from the decline in mortgage rates.
This Stock is Providing Potential for Huge Opportunity within the Health Care Industry
Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) is strategically poised to take advantage of business opportunities in the global health care industry.
The most recent global report from the United Nations states that by 2030 the global population will reach 8.6 billion . This predicted growth in global population presents many potential problems. Some of these problems are obvious; shelter, food etc…
What about Healthcare? Did you know that currently for every 1,000 healthcare patients there are only 3 doctors available to provide treatment ?
This massive shortcoming in patient care has created a serious problem for patients and healthcare providers! It has also opened the doors wide open for companies – and investors – to immediately capitalize. Companies in the healthcare sector are making key investments in telemedicine and machine learning to take the quality of care to the next stage.
THE PROBLEM: The Health Care System is Dated & Broken!
- Rising Costs: Governments and payors facing increasing costs that are simply unsustainable.
- Inefficient Use of Resources: 39% of Canadians who visited an ER indicated that they could have avoided the visit if they had better access to primary care.
- Doctor Supply: A shortage of primary care doctors and nurses, especially in remote and rural communities, leads to clinician burn out and patients frustrated by long wait times. Newly licensed doctors are avoiding primary care because of these dynamics, which increases the pressure on an already stressed system.
- Accessibility: Approximately 15% of Canadians aged 12 and older don’t have a primary care physician. Nearly two-thirds (59%) of seniors are unable to get a same-or next-day appointment. Almost 7 in 10 Canadians avoid seeing a doctor when they are sick.
THE PREMIER HEALTH SOLUTION:
- On Your Time: Patients can book appointments & be seen by general practitioners & specialists 24/7.
- Ease of Access: Patients, Doctors, Nurses & Pharmacists can review your medical chart in real-time, anytime.
- No Borders: Doctors can be anywhere in the world and still see their patients. Patients can visit any clinic and have their medical charts follow them.
- At Your Convenience: Prescriptions electronically submitted to the pharmacy of their choice or delivered free to them by a preferred pharmacy partner.
The public is beginning to take notice of Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI). The company has nearly 3,000,000 (three million) patients, an ecosystem of 290 clinics, and 4,600 licensed practitioners. (OTC: PHGRF) / (CSE: PHGI) is Connecting the human skill-based expertise with proprietary Artificial Intelligence, Premier is positioning to be a leading force in this rapidly expanding digital health industry, right now!
Premier’s Industry-Changing Intelligence
When it comes to healthcare technology, there have been few moonshot moments that have dramatically changed the face of the industry. While the healthcare juggernauts work to simply expand their reach with archaic technology, Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) has identified an open opportunity to capitalize on.
It Starts With Industry-Leading Technology
Through the use of HealthVue, a wholly-owned subsidiary of Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI), has built a medical ecosystem with the ability to directly connect to pharmacists, nurses, and physicians in real time. With a high number of family physicians quitting and high overhead, doctors are beginning to avoid private practices entirely. This is a HUGE problem especially in countries that actually have “Free Healthcare” like Canada.
In other cases, smaller clinics don’t have the resources for adequate patient follow-up. Implementing Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI)’s systematic process could significantly improve the quality of care and improve patient health outcomes.
Acquisitions & Strategic Ventures Target Substantial Growth Opportunities For Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI)
Unlike most micro-cap companies, Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) is in the prime position to take a page out of the industry’s leading corporations. What do we mean? Premier Health is hot on the trail of strategic ventures and acquisitions right now.
On January 29, Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) closed on one of its biggest acquisitions to date and brought on CLoud Practice Inc. For someone new to this story, what does this actually mean?
This acquisition brings on several key assets:
- Juno EMR (Electronic Medical Record) Cloud-Based Solution.
- ClinicAid, a Medical Billing Software.
- MyHealthAccess, an Online Patient Portal.
More importantly, Juno’s EMR, in particular, gives Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) access to a system that is currently used by, 287 Clinics, over 3,000 Licensed Practitioners, 1,500 Medical Staff, and 2,870,000 Registered Patients. What’s more, is that the company has just beefed up its technology team in order to deliver a patient-centric platform and mobile app with a beta version becoming available by end of Q2.
This Gets So Much Better… the medical billing software, ClinicAid, processes upwards of $30,000,000 in payments to over 3000 health providers EACH MONTH. This acquisition gives Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) immediate access to added cash flow and earnings growth.
The Cannabis Connection: No Longer a Low Tide For Cannabis & Premier Is Setting Its Sights
We are seeing a tidal shift in public opinion regarding the cannabis sector and the potential benefits of incorporating medicinal cannabis and CBD into healthcare. Leaping ahead, Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) announced in late 2018 plans for launching a Cannabis Clinic.
Dr. Essam Hamza, CEO of Premier Health, shared that “the role of Cannabis in treating medical conditions is continuously expanding. Our doctors have had success in treating patients with various ailments from chronic pain to cancer-related symptoms. There is a gap between the patient’s need for medical marijuana, and the family doctor’s comfort and knowledge to prescribe it.”
The Canadian medical cannabis market is estimated to be worth approximately $2.35 billion by 2025  and Premier is already diversifying its revenue potential.
The Evolution Continues With New, Cutting Edge Technology
Let’s paint this picture for you: Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) has access to MILLIONS of patients and is now at the forefront of a significant pivot for healthcare and cannabis.
Traditionally, there are two types of patients right now: medical patients who are brand new to medical cannabis and others who are active users that are well aware of the benefits. Being that there are currently 4,600 physicians & healthcare practitioners who use Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI)’s Juno EMR platform, this latest agreement could mean big opportunities for Premier. Why is all of this important?
CB2 Insights just integrated its technology with Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI). And why this deal could be big for Premier is based on CB2 and its unique technology platform that could drastically change the medical cannabis industry. Let’s explain:
Access to knowledgeable practitioners is a huge hurdle for the medical cannabis industry.
The Premier Solution & A First To Market Opportunity?
Not only does the latest deal open up a major opportunity for a company like CB2, it effectively brings Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) to the forefront to offer an all-inclusive platform for nearly 5,000 doctors & healthcare practitioners to prescribe medical cannabis to millions of patients across North America.
The unique feature of the CB2 Clinical Decision Support (CDS) tool is that the technology dramatically cuts the learning curve for medical providers. Those who may not be completely educated on different variants of cannabis can efficiently determine a proper strain/product for patients based on thousands of datapoint collected by CB2’s platform.
“We continue to receive multiple requests from physicians who ask about how best to incorporate medical cannabis into their clinics. This agreement with CB2 will provide us a robust, validated tool to give our physicians and healthcare practitioners a safe and secure way to qualify, educate and where appropriate, prescribe medical cannabis to their patients in a compliant manner.”
CB2 gathers data at the point-of-care in a HIPAA-compliant manner, both aggregated and anonymized, to study trends and outcomes that work to educate and support stakeholders including but not limited to physicians and other healthcare professionals. Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) essentially becomes the gatekeeper to millions of patients and, now thousands of practitioners who can feel comfortable prescribing different medical cannabis based on the results from CB2’s CDS Tool.
Latest News (3/27/2019):
Premier Health (OTC: PHGRF) (CSE: PHGI) Signs Agreement with CB2 Insights to Integrate Medical Cannabis Clinical Decision Support Tool
Traditional Health Care Is Transforming
In recent months, healthcare companies have explored integrating augmented reality technology into care offerings. According to recent reports, the healthcare-based AR market is projected to be worth over $5 billion by 2025 .
Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) is investing in augmented reality technology to be at the forefront of this new opportunity. Premier dominated headlines when the Company’s executive leadership team announced plans to collaborate with NexTech AR Solutions to explore bringing AR technology to its patient-centric healthcare app.
Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) will work with NexTech to develop educational tools for healthcare professionals and patients through the use of augmented reality technology. The potential applications of AR in training medical professionals are endless because the tech creates an incredibly engaging educational experience.
Imagine medical professionals being able to take their anatomical education one step further by interacting with a virtual representation of the human heart, and demonstrate to their patients exactly what is going on internally.
“At Premier Health, we pride ourselves on being at the forefront of changes in healthcare, so we are thrilled to be a part of the future of healthcare by enabling state of the art technological advancements to our patient-centric telemedicine app. AR has the potential to revolutionize both the access to data and the delivery of healthcare. The technology will help doctors and patients alike — doctors will have access to the latest and most relevant information about their patients while patients can use AR for self-education and improving the quality of treatment they receive.”
Just as Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) did with its Cloud Practice acquisition, it has continued to execute on with other irons in the fire. Furthermore, Premier isn’t just focusing on cloud-based tech but also on brick and mortar. Earlier in 2019, the company entered into a letter of intent to acquire 2 operating pharmacies doing about $6 million in revenue and were cash flow positive.
On April 2 Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) entered into a formal agreement to complete this acquisition! This isn’t just some random brick and mortar business; we’re talking a business doing about $6 million in revenue. Premier Health expects to complete the acquisition during the second quarter of 2019. Those looking at Premier Health Group right now are seeing it at the exact moment of several huge milestones and this is one of them.
What could be even better yet is that this deal could seamlessly integrate with EVERYTHING else that the company has in place…and the CEO agrees:
“We look forward to working together to improve fulfillment for our rapidly growing patient base. In light of our recent announcement of our medical cannabis decision tool for our JUNO EMR clients, our pharmacists will be able to help with patient education and support regarding medical cannabis. In addition, with one of the pharmacies occupying a space of over 6,000 square feet, we have the potential to open a new medical and/or cannabis clinic within the existing space.”
Is Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) set to become the next market leader? Take a look at Teladoc Health Inc. (TDOC), a company which currently services over 130 countries around the world. It reported Q4 and full-year 2018 results  that showed revenue increased by nearly 80% for the year! While this is impressive on its own, you may want to take a look at another important figure: total telemedicine visits grew by 80%.
The company made headlines after inking a deal with CVS Health to provide virtual healthcare offerings for patients with minor illnesses from their mobile device. While this is great news for Teladoc, this could be even greater news for Premier Health and here’s why: Companies at the forefront of the healthcare industry revolution are working to develop more innovative care offerings to lower costs and increase access to care. Artificial intelligence, big data analytics, and telemedicine are helping to lead the way.
It’s not hard to believe that two of the best performing sectors in the market have been technology and healthcare. Premier Health Group Inc. (OTC: PHGRF) (CSE: PHGI) provides exposure to both of these sectors. Not only has it built a framework to expand its reach into the multi-million patient range but it has also strategically positioned itself for bigger opportunities in our opinion.
Being at the start of something is what many dreams of and Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) continues to expand its operations. The latest deal with CB2 Insights could set the standard for doctor/patient engagement & medical marijuana prescriptions.
The partnership with 360 Health brings the company to service a country that has over a billion people living there. And its continued expansion through acquisitions of companies adding new technologies, new patients, and access to more healthcare professionals could set the stage for something even greater for the company.
- World Population Stats http://www.un.org/en/development/desa/population/events/pdf/other/21/21June_FINAL%20PRESS%20RELEASE_WPP17.pdf
- Doctors per patient https://www.nationmaster.com/country-info/stats/Health/Physicians/Per-1%2C000-people
- The Growth of Canada’s Medical Cannabis Market https://newfrontierdata.com/marijuana-insights/canadian-market-projected-growth-2/
- Healthcare AR market Value https://www.grandviewresearch.com/press-release/global-augmented-reality-ar-virtual-reality-vr-in-healthcare-market
- Teladoc Financial Results https://www.fiercehealthcare.com/tech/teladoc-reports-significant-gains-revenue-virtual-visits-2018
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. Midam was hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). Midam has been compensated an additional $100,000 by Premier Health Group to extend the period of coverage to June 1, 2019. As of 3/26/2019 Midam has been compensated an additional $100,000 by Premier Health Group for additional coverage without further extended coverage duration. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. FULL DISCLAIMER HERE
Will Stock Prices Head Higher On Thursday?
US stocks were mixed on Thursday. As most investors head into a long holiday weekend, there are several things helping to drive stock prices higher on Thursday.
IPOs Boost Market Sentiment
On April 18 the stock market saw two big IPOs. Both Zoom Video (ZM) and Pinterest (PINS) made their public debuts. For the most part, investors remained skiddish about the latest series of IPOs. What was the reason? A few weeks ago the market witnessed the much anticipated Lyft (LYFT) IPO that has ended is disaster.
The day that Lyft went public, share prices briefly hit highs of $88.60 before closing the day in the red. This trend hasn’t stopped since then. Current stock prices show the company’s shares trading around $55. This abysmal figure is a far cry from even its IPO price of $72.
Needless to say, both Pinterest and Zoom have remained relatively flat. Zoom shares traded in a range of $$60.32 to $66. Pinterest saw a trading channel of $23.05 to $24.99.
Micro-Cap Stocks Rally Back
During the early morning session, the Russell Microcap Index saw a sharp drop to lows of $578.33. But since then, the index has continued to rally higher, nearly surpassing its opening price as of 12:30 PM. What is a microcap stock? These stocks represent companies with a market capitalization of $50 million to $300 million. Traditionally, investors will see plenty of penny stocks on the list.
The higher volatility attracts investors to these equities. This morning, the stock price for a few microcap companies ended up skyrocketing on heavy volume. Among the list of penny stocks, Amyris Inc. (AMRS), Mustang Bio (MBIO), Precipio Inc. (PRPO) and Uxin Limited (UXIN) hit scanners for volume and price movement.
With the short week, it’s likely that the markets could slow down during the afternoon session. Looking ahead to next week, investors will be watching for several key figures notwithstanding the growing list of companies reporting earnings.
Search Stock Price (StockPrice.com)
Sponsored Content2 months ago
Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market
Featured5 months ago
Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond
Cannabis4 months ago
Two Massive Growth Industries, One Choice for Investors
Biotechnology3 months ago
Big Investments Are Signaling The Green Light For A ‘Hot Market’ With Cancer-Fighting Stocks
Featured2 months ago
This New Technology Could Transform A Multi-Billion-Dollar Industry!
Cannabis3 months ago
A New Cannabis Trend That The Market Should Take Immediate Notice Of Is Here!
Biotechnology1 month ago
PharmaCyte Biotech (PMCB) and UTS Creating Advanced Version of Melligen Cells to Treat Diabetes
Biotechnology2 months ago
The Future Of Drug Delivery Has Biotech Investors Focusing On One Small Company